Research field (3):
Tumor diagnostics and therapeutics
, Tumor biology
, General surgery, pediatric surgery
Research theme for competitive and other funds (9):
2022 - 2025 乳癌におけるのAbscopal効果の検証と放射線療法効果モニタリングの開発
2017 - 2022 Clinical significance of ABCG2/BCRP quantified by fluorescence nanoparticle in breast cancer patients undergoing neoadjuvant chemotherapy
2016 - 2020 A cohort study in relation to lifestyle factors responsible for improvement of cancer patient survival and quality of life
2017 - 2019 Prediction for treatment in breast cancer using T cell and B cell repatoire analysis.
2015 - 2017 Quantitative evaluation of estrogen receptor and the validation for breast cancer by nano particle-based immunohistochemistry
2014 - 2017 Quantification of breast cancer microenvironment by three dimensional integration of micro bubble contrast ultrasound and MRI image
2013 - 2017 Basic construction for treatment effect prediction of molecular targeted drugs by quantitative estimation of HER family receptor based on highly sensitive nanoparticle imaging
2014 - 2016 Construction of the treatment algorithm for triple negative breast cancer
2010 - 2012 Elucidation of the biological properties of triple negative breast cancer and construction of a therapeutic strategy
Show all
Papers (138):
Yasuaki Sagara, Hiraku Kumamaru, Naoki Niikura, Minoru Miyashita, Takaaki Konishi, Takayuki Iwamoto, Naoko Sanuki, Kenta Tanakura, Masayuki Nagahashi, Naoki Hayashi, et al. 2020 Annual Report of National Clinical Database-Breast Cancer Registry: 10-year mortality of elderly breast cancer patients in Japan. Breast Cancer. 2024
Yuechen Wang, Narumi Harada-Shoji, Narufumi Kitamura, Yuto Yamazaki, Akiko Ebata, Masakazu Amari, Mika Watanabe, Minoru Miyashita, Hiroshi Tada, Takaaki Abe, et al. Mitochondrial dynamics as a novel treatment strategy for triple-negative breast cancer. Cancer medicine. 2024. 13. 2. e6987
Minoru Miyashita, Hiraku Kumamaru, Naoki Niikura, Yasuaki Sagara, Takaaki Konishi, Takayuki Iwamoto, Naoko Sanuki, Kenta Tanakura, Masayuki Nagahashi, Naoki Hayashi, et al. Annual report of the Japanese Breast Cancer Registry for 2019. Breast Cancer. 2023
Mitsuo Terada, Aki Ito, Yuichiro Kikawa, Kei Koizumi, Yoichi Naito, Tatsunori Shimoi, Mikiya Ishihara, Takashi Yamanaka, Yukinori Ozaki, Fumikata Hara, et al. The Japanese Breast Cancer Society Clinical Practice Guidelines for systemic treatment of breast cancer, 2022 edition. Breast cancer (Tokyo, Japan). 2023. 30. 6. 872-884
核外ERαの定量分析に基づくHR+/HER2乳癌の内分泌療法抵抗性の予測(Prediction of endocrine therapy resistance in HR+/HER2 breast cancer based on quantitative analysis of extranuclear ERα)
(日本癌学会総会記事 2019)